---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-031043"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2022-11-09T23:59:59+00:00"
generated_at: "2026-06-22T02:36:01.717083+00:00"
event_type: "other"
sentiment: "negative"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech say-on-pay fails at 2022 annual meeting; directors elected

## Summary
- Directors elected: Thomas K. Equels (7.65M for, 4.71M withheld), William M. Mitchell (4.33M for, 8.03M withheld), Stewart L. Appelrouth (4.32M for, 8.04M withheld).
- Ratification of BDO USA as auditor passed: 19.95M for, 1.88M against, 0.37M abstain.
- Non-binding advisory vote on executive compensation failed: 2.04M for, 10.21M against, 0.11M abstain, with 9.83M broker non-votes.
- Approximately 48.05M shares eligible to vote; quorum of 40% met.

## SEC filing metadata
- accession: 0001493152-22-031043
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2022-11-09T23:59:59+00:00
- event_type: other
- sentiment: negative
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315222031043/0001493152-22-031043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315222031043/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-031043
- JSON: https://secwatch.observer/filing/0001493152-22-031043.json
- Plain text: https://secwatch.observer/filing/0001493152-22-031043.txt

## Key facts
- Shareholder Votes
  AIM ImmunoTech Inc. shareholders approved Ratification of the selection of BDO USA, LLP as the Company's independent auditors for the fiscal year ending December 31, 2022 at the 2022-11-03 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2022-11-03
  source text: Ratification of the selection of BDO USA, LLP as the Company’s independent auditors for the fiscal year ending December 31, 2022 : For: 19,946,910 Against: 1,876,423 Abstain: 366,347
  evidence_url: https://www.sec.gov/Archives/edgar/data/946644/000149315222031043/0001493152-22-031043-index.htm
- Shareholder Votes
  AIM ImmunoTech Inc. shareholders approved Election of Directors at the 2022-11-03 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2022-11-03
  source text: Election of Directors : The following three director nominees were each elected to serve a term ending at the Company’s Annual Meeting of Stockholders for 2023, or until their successors are duly elected and qualified: Nominees For Withheld Broker Non-Votes Thomas K. Equels 7,652,988 4,705,546 9,831,146 William M. Mitchell 4,330,110 8,028,424 9,831,146 Stewart L. Appelrouth 4,319,085 8,039,449 9,831,146
  evidence_url: https://www.sec.gov/Archives/edgar/data/946644/000149315222031043/0001493152-22-031043-index.htm
- Shareholder Votes
  AIM ImmunoTech Inc. shareholders rejected Approval, by non-binding vote, of executive compensation at the 2022-11-03 meeting.
  - Proposal: say on pay
  - Outcome: failed
  - Meeting: 2022-11-03
  source text: Approval, by non-binding vote, of executive compensation : For: 2,036,994 Against: 10,213,253 Abstain: 108,287 Broker Non-Votes: 9,831,146
  evidence_url: https://www.sec.gov/Archives/edgar/data/946644/000149315222031043/0001493152-22-031043-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.